duocarmycin sa has been researched along with Body Weight in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hudson, R; Patel, D; Suthe, SR; Wang, MH; Yao, HP | 1 |
1 other study(ies) available for duocarmycin sa and Body Weight
| Article | Year |
|---|---|
Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase.
Topics: Animals; Body Weight; Cell Line, Tumor; Duocarmycins; Humans; Immunoconjugates; Mice; Neoplasms; Proto-Oncogene Proteins c-met; Xenograft Model Antitumor Assays | 2022 |